Miikana Comes Together As An Oncology Drug Developer

Oct. 8, 2003

By Aaron Lorenzo

Flamel Raises $62M Through Sale Of Its Common Shares

Oct. 8, 2003

By Aaron Lorenzo

Ingenium Broadens Relationship With Elan For Target Validation

Oct. 7, 2003

By Aaron Lorenzo

Ingenium Broadens Relationship With Elan For Target Validation

Oct. 7, 2003

By Aaron Lorenzo

Flamel Raises $62M Through Sale Of Its Common Shares

Oct. 6, 2003

By Aaron Lorenzo

Ariad Gets $41M In Private Sale For Drug Development

Oct. 6, 2003

By Aaron Lorenzo

Ariad Gets $41M In Private Sale For Drug Development

Oct. 6, 2003

By Aaron Lorenzo

Flamel Raises $62M Through Sale Of Its Common Shares

Oct. 6, 2003

By Aaron Lorenzo

Biosyn Eyeing $10M For HIV Product Development Program

Oct. 3, 2003

By Aaron Lorenzo

Biosyn Eyeing $10M For HIV Product Development Program

Oct. 3, 2003

By Aaron Lorenzo